San Diego-based mostly Viking Therapeutics marked alone as a significant competitor during the weight loss drug industry in February immediately after revealing promising info from a mid-phase trial of experimental drug VK2735, which advised it rivaled—and outperformed—Novo and Lilly drugs when specified to be a weekly injection As well as in M